(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-FirstC... global specialty biopharmaceutical company, today...pean Medicines Agency for,velaglucerase alfa, the ...t,for the treatment of Type 1 Gaucher disease. Thi...rase alfa that has been submitted, with previous,s...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswire... ) today announced that Randy Scott, Genomic Healt...nnual Piper Jaffray Health Care Conference in New ...m. ET. ,, To access the live and subsequently ...vestor Relations section of Genomic Health,s websi...
(Date:11/24/2009)... Program Connects Customers wi...es Collected with DNA Genotek Products , ...09 -- DNA Genotek , a leading provider of product...and preparation, today announced its new global pa...ncements for DNA Genotek,s partner community and i...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3...rence Call To Be Held Friday, November 14, 2008 at... Time, HOPKINTON, Mass., Nov. 13 Alseres,Pharma...rational and,financial results for the quarter end...tion for fiscal year 2008., (Logo: http://www.ne...e are encouraged by the progress we have made on o...
...SDA, Md., Nov. 13 Spherix Incorporated,(Nasdaq: ...months ended,September 30, 2008 of $1.7 million ($..., respectively. Research and development and marke...urlose as a treatment for Type,2 diabetes were app...ended,September 30, 2008, compared to approximatel...
...RBOR, Mich., Nov. 13 NanoBio Corporation announce...entations that detail,milestones in its clinical a...is, acne, herpes labialis and genital herpes durin...tists (AAPS) meeting November 16-20,2008 in Atlant...ng the conference:, Tuesday, November 18, 1:00 PM...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 2Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 3Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 4Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results 5Spherix Reports 3rd Quarter Earnings 2NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists 2...s a,paradigm in life science and drug development ...p;D companies. In many occasions I,ve,seen very pr...anned,because no money was to be made with it, eve... usual strategy to avoid this fate is to find,a dr... addition to the,"non-profitable" one. PLoS Medeci...
...l application involving the buzzword "nano" - canc... resonance imaging) : ,Accurate staging of cancer...p of patients for both prediction of prognosis and...And an essential part of this work,up is assessing...urrent,methods include surgical removal of nodes f...
...mes a,potential target for a drug seems very promi...reality. Its the case of telomerase inhibitors,to ...rtal" (able to,divide indefinitely) aspect of canc...k their function, preventing them to inhibit compl...roject? Look for something,else? Hell no! Look out...
Other Biology News:Finding Cures For Tropical Diseases: Is Open Source An Answer? 2Imaging Lymph Nodes with Nanoparticles 2GATA: a graphic alignment tool for comparative sequence analysis 2...via cardiac puncture from 3 to 4 week old rabbits ...uged and frozen at -70C. The complement is thawed,...tored at -70C. DIRECT SALES FROM PEL-FREEZ BIOLOGI..., YOU CAN NOW BUY DIRECTLY FROM THE SOURCE! FORMER...
Dacron mesh button tether single channel infusion of rats, sterile from Instech Solomon
GIBCO Donor Calf Serum from Invitrogen
Genes VI from Promega
Biology Products: